Kailera Therapeutics, Inc. (KLRA) Institutional Ownership & Insider Trading
99 institutions reported holding Kailera Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 5 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · read by EquiReason
KLRAKailera Therapeutics, Inc.Follow KLRA — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters99 institutions held 89.6% of the shares. Across filers that reported both quarters, shares held changed —.
Largest moves, shares (millions)
Kailera Therapeutics, Inc. — questions
- Who owns Kailera Therapeutics, Inc. stock?
- 99 institutions reported Kailera Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Bain Capital Investors LLC (20.3%), Bain Capital Life Sciences Investors, LLC (17.4%), RTW INVESTMENTS, LP (8.3%).
- Are Kailera Therapeutics, Inc. insiders buying or selling?
- 5 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Kailera Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.